Roche gets NICE approval for breast cancer drug Kadcyla after years of battles
admin 15th June 2017 Uncategorised 0Following four years of beating up on each other over the cost-benefit of Roche’s cutting-edge breast cancer drug Kadcyla, and heavy lobbying from cancer advocacy groups, the Swiss drugmaker and the U.K. drug cost watchdog have come to an accommodation.
More: Roche gets NICE approval for breast cancer drug Kadcyla after years of battles
Source: fierce